FEMSelect Company
.jpg)
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. FEMSelect (formerly POP Medical Solutions) has developed a minimally invasive, meshless, dissectionless approach to pelvic organ prolapse repair. The device has been cleared by the FDA and CE Marked and is available commercially.
Industry:
Pelvic & Uterine Healthcare
Headquarters:
Modi'in, HaMerkaz, Israel
Founded Date:
01-01-2012
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
9
Total Funding:
$12,795,000
Last Funding Date:
2022-10-19
Last Funding Type:
Series B
Register and Claim Ownership